CD8+ T lymphocytes are the major cell population involved in the early gamma interferon response and resistance to acute primary Toxoplasma gondii infection in mice
- PMID: 7869956
- DOI: 10.1111/j.1348-0421.1994.tb01858.x
CD8+ T lymphocytes are the major cell population involved in the early gamma interferon response and resistance to acute primary Toxoplasma gondii infection in mice
Abstract
Gamma interferon (IFN-gamma) is known to be a major mediator influencing host defense against Toxoplasma (T.) gondii. To evaluate lymphocyte populations involved in this cytokine-mediated early resistance to T. gondii, the effects of in vivo administration of monoclonal antibodies (MAbs) against T-cell subsets and anti-asialo GM1 antibody on the course of infection and IFN-gamma response were investigated in mice infected acutely with this parasitic protozoan. A single injection of anti-CD8 MAb on day -1 or day 4 severely exacerbated the infection, in accordance with a marked suppression of endogenous IFN-gamma production. Moreover, the administration of anti-IFN-gamma MAb on day 0 but not later than day 4 resulted in a total abrogation of resistance to T. gondii, suggesting that endogenous IFN-gamma produced during the first several days of infection is critical for the generation of antitoxoplasmal resistance in mice. In contrast, no significant increase in mortality was observed when injected with either anti-CD4 MAb or anti-asialo GM1 antibody on day -1, while these antibodies reduced significantly the ability of mice to produce IFN-gamma. Indeed, simultaneous depletion of CD4+ and CD8+ cells had no greater suppressive effect on host defense and endogenous IFN-gamma production than depletion of CD8+ cells alone. Together, these results suggest that CD8+ T cells play a central role for resolution of acute toxoplasmosis by participating in endogenous IFN-gamma production. The possible role of early produced IFN-gamma in the development of protective immune response to T. gondii is also discussed.
Similar articles
-
Importance of early gamma interferon production in Propionibacterium acnes-induced resistance to Toxoplasma gondii infection in mice.J Vet Med Sci. 1994 Apr;56(2):293-7. doi: 10.1292/jvms.56.293. J Vet Med Sci. 1994. PMID: 8075217
-
Endogenous gamma interferon-independent host resistance against Listeria monocytogenes infection in CD4+ T cell- and asialo GM1+ cell-depleted mice.Infect Immun. 1991 Oct;59(10):3439-45. doi: 10.1128/iai.59.10.3439-3445.1991. Infect Immun. 1991. PMID: 1680104 Free PMC article.
-
Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.J Immunol. 1991 Jan 1;146(1):286-92. J Immunol. 1991. PMID: 1670604
-
The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection.Parasitol Int. 2020 Jun;76:102030. doi: 10.1016/j.parint.2019.102030. Epub 2019 Nov 25. Parasitol Int. 2020. PMID: 31778800 Free PMC article. Review.
-
Cytokines and immunological control of Eimeria spp.Int J Parasitol. 1995 Nov;25(11):1331-51. doi: 10.1016/0020-7519(95)00069-e. Int J Parasitol. 1995. PMID: 8635884 Review.
Cited by
-
An Important Role for CD4+ T Cells in Adaptive Immunity to Toxoplasma gondii in Mice Lacking the Transcription Factor Batf3.mSphere. 2020 Jul 15;5(4):e00634-20. doi: 10.1128/mSphere.00634-20. mSphere. 2020. PMID: 32669460 Free PMC article.
-
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria.Infect Immun. 1997 May;65(5):1593-8. doi: 10.1128/iai.65.5.1593-1598.1997. Infect Immun. 1997. PMID: 9125535 Free PMC article.
-
Secretory Microneme Proteins Induce T-Cell Recall Responses in Mice Chronically Infected with Toxoplasma gondii.mSphere. 2019 Feb 27;4(1):e00711-18. doi: 10.1128/mSphere.00711-18. mSphere. 2019. PMID: 30814319 Free PMC article.
-
ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18.J Exp Med. 2011 Jul 4;208(7):1533-46. doi: 10.1084/jem.20101660. Epub 2011 Jun 13. J Exp Med. 2011. PMID: 21670204 Free PMC article.
-
New advances in immune mechanism and treatment during ocular toxoplasmosis.Front Immunol. 2024 May 10;15:1403025. doi: 10.3389/fimmu.2024.1403025. eCollection 2024. Front Immunol. 2024. PMID: 38799473 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials